These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28170096)

  • 41. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
    Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
    J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Changes and clinical significance of peripheral blood natural killer cells in neonates with bacterial pneumonia].
    Li Q; Weng K; Zhu L; Mei X; Xu L; Lin J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1067-70. PubMed ID: 25270210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY; Yang BY; Wu CY
    Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-frequency, exhausted immune status of CD56
    Pan Z; Zhao R; Shen Y; Liu K; Xue W; Liang C; Peng M; Hu P; Chen M; Xu H
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108369. PubMed ID: 34844872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined low dose cyclosporine and prednisone down-regulate natural killer cell-like effector functions of CD8brightCD56+ T cells in patients with active Behçet uveitis.
    Ahn JK; Park YG; Park SW; Yoon KC; Yu HG; Chung H
    Ocul Immunol Inflamm; 2006 Oct; 14(5):267-75. PubMed ID: 17056460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.
    Reeves RK; Gillis J; Wong FE; Yu Y; Connole M; Johnson RP
    Blood; 2010 Jun; 115(22):4439-46. PubMed ID: 20339088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A population of atypical CD56(-)CD16(+) natural killer cells is expanded in PTSD and is associated with symptom severity.
    Bersani FS; Wolkowitz OM; Milush JM; Sinclair E; Eppling L; Aschbacher K; Lindqvist D; Yehuda R; Flory J; Bierer LM; Matokine I; Abu-Amara D; Reus VI; Coy M; Hough CM; Marmar CR; Mellon SH
    Brain Behav Immun; 2016 Aug; 56():264-70. PubMed ID: 27025668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.
    Bonacini M; Soriano A; Zerbini A; Calò E; Cimino L; Muratore F; Fontana L; Braglia L; Parmeggiani M; Salvarani C; Croci S
    Front Immunol; 2018; 9():2157. PubMed ID: 30319620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The early expansion of anergic NKG2A
    Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The biology of human natural killer-cell subsets.
    Cooper MA; Fehniger TA; Caligiuri MA
    Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
    Gomez-Muñoz L; Perna-Barrull D; Villalba A; Rodriguez-Fernandez S; Ampudia RM; Teniente-Serra A; Vazquez F; Murillo M; Perez J; Corripio R; Bel J; Vives-Pi M
    Front Immunol; 2020; 11():611522. PubMed ID: 33569058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
    Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
    Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
    J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population.
    Marquardt N; Wilk E; Pokoyski C; Schmidt RE; Jacobs R
    Eur J Immunol; 2010 May; 40(5):1428-39. PubMed ID: 20186880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis.
    Lünemann A; Tackenberg B; DeAngelis T; da Silva RB; Messmer B; Vanoaica LD; Miller A; Apatoff B; Lublin FD; Lünemann JD; Münz C
    Int Immunol; 2011 Feb; 23(2):139-48. PubMed ID: 21212154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.